NAV NAVCO Pharmaceuticals Inc.
NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives industries to combat microorganisms. NAVCO Pharmaceuticals Inc. is headquartered in Vancouver, Canada.…
Industry Peers
Drug Manufacturers - Specialty & GenericKey Statistics
About NAVCO Pharmaceuticals (CVE: NAV)
›
NAVCO Pharmaceuticals (CVE: NAV) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector.
The shares were at 0.0050 CAD on 18 November 2026, roughly unchanged over 52 weeks. Its 52-week range is 0.0050 CAD to 0.0100 CAD, and it trades at the bottom of that range.
Its market capitalisation is 285.35K CAD.
NAVCO Pharmaceuticals reports an operating margin of 0.0%.
Its debt exceeds its cash by 110.41K CAD. Its Piotroski F-score is 0 out of 9, a weak reading of its financial health. The next earnings report is expected on 28 January 2027.